Merck Frosst
Patients and Caregivers

Rotavirus

References

  1. Offit PA and Clark HF. Rotavirus. Chapter 139. In: Mandell, Douglas & Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone; 2000. Vol. 2:1696-702.

  2. Dormitzer PR. Rotaviruses. Chapter 146. In: Principles and practice of infectious diseases. 6th ed., 2005.

  3. Data on file, Merck Frosst Canada Ltd.: RotaTeqTM-Product Monograph, July 2006.

  4. Ford-Jones EL et al. Rotavirus-associated diarrhea in outpatient settings and child care centers. Arch Pediatr Adolesc Med 2000;154(6):586-93.

  5. Matson DO. Rotaviruses. Chapter 232. In: Principles and Practice of Pediatric Infectious Diseases. 2nd ed., 2002:1104-10.

  6. Blacklow NR. Viral gastroenteritis. Chapter 75. In: Gorbach, Bartlett, Blacklow, eds. Infectious Diseases. 3rd ed, 2004:677-81.

  7. King CK et al. Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: Oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003;52(RR-16):1-16.

  8. Rivest P et al. Hospitalisations for gastroenteritis: The role of rotavirus. Vaccine 2004;22:2013-7.

  9. Cohen J and Powderly W. Rotaviruses. In: Infectious Diseases. 2ndEd., 1999.

  10. Ansari SA et al. Comparison of cloth, paper, and warm air drying in eliminating viruses and bacteria from washed hands. Am J Infect Control 1991;19(5):243-9.

  11. Vesikari T et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23-33.

This product information is intended only for residents of Canada.

®Registered Trademark of Merck & Co., Inc.  Used under license.

This site is for residents of Canada. / This site was updated on October 26, 2011.